Earnings Call · Q4 FY2022·2023-03-15

Q4 22EPS +6.06%·Rev n/aQ3 22EPS +18.75%·Rev n/aQ2 22EPS -16.00%·Rev n/aQ1 22EPS 0.00%·Rev n/a⚠ consensus missing

CAPRICOR THERAPEUTICS, INC. CAPR

AJ Bergmann — Chief Financial Officer

Linda Marban — Chief Executive Officer

−3.7%1d on move date−3.0% vs SPY3d−6.5%5d−5.2%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CAPR calls or request research access.

More CAPR calls Browse calls Request research access